INTRODUCTION
============

The endoplasmic reticulum (ER) is a membrane-bound organelle essential for the folding of virtually all secreted and membrane proteins in eukaryotic cells. Environmental, pathological, or physiological processes that interfere with ER protein folding cause ER stress. Cells activate a set of intracellular signaling pathways, termed the unfolded protein response (UPR), when they are confronted with ER stress. In metazoans, the UPR is controlled by three ER-resident transmembrane proteins that activate distinct transcriptional and translational programs in response to ER stress: inositol-requiring enzyme 1 (IRE1), PKR-like endoplasmic reticulum kinase (PERK), and activating transcription factor 6 (ATF6; [@B52]). The UPR can alleviate ER stress and enhance cell survival by increasing the fidelity of protein folding, promoting ER-associated degradation of misfolded proteins, and attenuating protein translation. If these measures fail to reduce ER stress, UPR signaling switches to promote cell death ([@B50]). ER stress--induced cell death is implicated in the pathogenesis and progression of diverse diseases, including inflammation, retinal degeneration, diabetes, and infections ([@B53]). To begin to dissect the roles of UPR signaling pathways in regulating cell death induced by chronic ER stress, we previously used chemical-genetic tools to selectively and robustly activate IRE1, PERK, or ATF6 in mammalian cells ([@B26], [@B27]; [@B21]; [@B5]). By this strategy, we found that chronic activation of the PERK arm, but not the IRE1 or ATF6 arm, of the UPR triggered apoptosis ([@B26], [@B27]). However, the precise mechanisms that promote apoptosis in response to chronic PERK signaling are poorly understood.

The PERK signaling pathway is the key regulator of translation during the UPR ([@B42]). In response to ER stress, PERK activates its cytosolic kinase domain to specifically phosphorylate the α-subunit of eukaryotic translation initiation factor 2 (eIF2α; [@B17]). Phosphorylated eIF2α inhibits the guanine nucleotide exchange factor, eIF2B, which converts inactive, GDP-bound eIF2 to active, GTP-bound eIF2 ([@B42]). Decreased levels of eIF2-GTP impede formation of the eIF2-GTP-tRNA^Met^ ternary complex required for translation initiation on mRNAs and thereby reduce protein synthesis ([@B42]). Rare mRNAs, such as the *Atf4* transcriptional regulator, are translated more effectively when eIF2α is phosphorylated because these mRNAs contain small noncoding upstream open reading frames (uORFs) that inhibit translation of the downstream protein-encoding open reading frame ([@B15]). When eIF2 activity is reduced through eIF2α phosphorylation during ER stress, ribosome assembly "skips" these inhibitory uORFs and instead increases translation from the ATF4 protein-encoding ORF ([@B28]). By this mechanism, PERK signaling also initiates a distinct transcriptional program during the UPR through production of transcriptional activators such as ATF4 ([@B18]). PERK\'s translational and transcriptional outputs profoundly influence cell survival positively and negatively during ER stress. Attenuation of protein synthesis by PERK\'s phosphorylation of eIF2α reduces ER protein folding demands and ER stress levels. Cells with *Perk*-null mutations or *eIF2α* mutated in serine 51 to nonphosphorylatable alanine (*eIF2α^S/S^* to *eIF2α^A/A^*) both show elevated protein synthesis and increased levels of misfolded proteins and succumb more readily to cell death in response to ER stress ([@B16]; [@B45]). Paradoxically, too much PERK signaling also promotes cell death, in part through its induction of the CCAAT/enhancer binding protein homologous protein (CHOP) proapoptotic transcription factor, itself a downstream transcriptional target of ATF4 ([@B55]; [@B15]; [@B43]). Indeed, *Chop^^−^/^−^^* cells are resistant to pharmacological and in vivo insults that trigger ER stress and cell damage ([@B35]; [@B36]). However, *Chop^^−^/^−^^* cells still undergo apoptosis in response to chronic ER stress ([@B55]), and overexpression of CHOP itself does not cause apoptosis ([@B14]). These findings suggest that additional CHOP-independent mechanisms regulate cell death downstream of PERK activation and eIF2α phosphorylation ([@B55]; [@B4]; [@B14])

Inhibitors of apoptosis (IAPs) are a conserved family of cytosolic proteins that regulate cysteine-dependent, aspartyl-specific proteases (caspases)---terminal executioners of cell death in metazoan cells ([@B44]). X-linked IAP (XIAP) is the most potent IAP inhibitor of caspases and is found in all mammalian cell types and tissues ([@B44]; [@B11]). XIAP directly binds and suppresses caspase proteolytic activity through its amino-terminal baculovirus IAP repeat domains ([@B9]). XIAP also contains a carboxyl-terminal RING zinc finger domain with E3 ubiquitin ligase activity that promotes ubiquitination and subsequent proteasomal degradation of substrates that also include caspases ([@B49]; [@B46]). By these two modes of suppressing caspase activity, XIAP serves as an important guardian against cell death. Because of XIAP\'s key role in influencing cell survival and apoptosis, multiple transcriptional, translational, and posttranslational mechanisms have evolved to regulate levels of XIAP in the cell ([@B11]; [@B12]). Here we find a significant down-regulation in XIAP protein levels in response to chronic ER stress. We find that XIAP down-regulation is robustly mediated via translational and posttranslational mechanisms specifically governed by the PERK arm of the UPR via eIF2α phosphorylation and ATF4 activity. Loss of XIAP results in increased sensitivity to ER stress--induced cell death that can be alleviated by restoring XIAP levels. Our findings define an unexpected link between the PERK signaling pathway and a key regulator of intrinsic apoptosis that contributes to cell death induced by chronic ER stress.

RESULTS
=======

Chronic ER stress down-regulates XIAP
-------------------------------------

We previously found that chronic exposure to ER stress led to down-regulation in the levels of proteins such as spliced XBP-1 and Grp78/BiP both in cell culture and in vivo ([@B26]). Both spliced XBP-1 and Grp78/BiP are important regulators of ER homeostasis, and their loss sensitizes cells to apoptosis ([@B25]; [@B30]; [@B26]). These findings suggested that reductions in levels of other regulators of cellular homeostasis in response to chronic ER stress might sensitize cells to apoptosis. To examine this possibility, we screened for proteins whose levels dropped significantly as a function of the duration of ER stress. One protein whose levels progressively fell in cells exposed to ER stress was XIAP. In HEK293 cells exposed to either tunicamycin or thapsigargin, XIAP steady-state protein levels significantly and progressively declined over the course of 48 h of drug treatment ([Figure 1A](#F1){ref-type="fig"}). The decline in XIAP correlated with increase in apoptosis, as evident by cell morphology and induction of molecular markers of apoptosis such as cleaved poly(ADP-ribose) polymerase (PARP; [Figure 1A](#F1){ref-type="fig"}). We next examined whether other cell types showed similar declines in XIAP protein levels. Similar to our findings in HEK293 cells, we found sharp and progressive drops in XIAP levels in all mammalian cell types we examined---HeLa, mouse embryonic fibroblast (MEF), Huh7, and HCT116---in response to chronic exposure to tunicamycin or thapsigargin ([Figure 1, B--E](#F1){ref-type="fig"}). By contrast to the sharp decline seen in XIAP protein levels in cells exposed to chronic tunicamycin or thapsigargin, we saw no drop in *Xiap* mRNA levels ([Figure 1F](#F1){ref-type="fig"}). Finally, we examined whether XIAP protein levels dropped in vivo in an animal model of P23H rhodopsin--induced retinal degeneration. Rhodopsin is a transmembrane light chromophore expressed solely in rod photoreceptors of the eye, and the P23H mutation is the most common cause of autosomal dominant retinitis pigmentosa in North America ([@B10]). The P23H mutation leads to rhodopsin protein misfolding in the ER, induction of ER stress, and progressive death of rod photoreceptors with ensuing vision loss ([@B48]; [@B22]; [@B37]; [@B6]). We collected retinas from wild-type and transgenic animals expressing P23H rhodopsin at postnatal day 90, an age when photoreceptors were undergoing cell death ([Figure 1G](#F1){ref-type="fig"}, left), and also found significantly reduced XIAP levels in P23H rhodopsin retinas compared with control ([Figure 1G](#F1){ref-type="fig"}, middle). Taken together, our findings demonstrated that down-regulation of XIAP protein is a conserved consequence of chronic ER stress in vitro and in vivo and that this drop correlates with the emergence of cell death.

![Chronic ER stress down-regulates XIAP protein but not *Xiap* mRNA. HEK293 (A), HeLa (B), MEF (C), Huh7 (D), and HCT116 (E) cells were treated with 5 μg/ml tunicamycin (Tm) or 500 nM thapsigargin (Tg) for the indicated hours. Cell lysates were immunoblotted for XIAP or cleaved PARP (cPARP). XIAP levels after Tm or Tg treatment from three different experiments were quantified by densitometry and are shown relative to XIAP levels in untreated cells (A--C). Asterisks indicate statistical significance (\**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001). Actin levels served as a protein loading control (A--E). (F) HEK293 cells were treated with Tm or Tg for indicated durations, and *Xiap* mRNA levels were measured by quantitative PCR (qPCR) and are shown relative to levels in untreated cells. (G) Retinas from wild-type (left) or P23H rhodopsin transgenic (right) rats were collected at postnatal day 90, and retinal protein lysates were probed for XIAP. HSP90 levels served as a protein loading control. A representative immunoblot from five different experimental animals is shown.](1411fig1){#F1}

The PERK arm of the UPR down-regulates XIAP
-------------------------------------------

The UPR is an attractive mechanism to regulate XIAP levels through its transcriptional, translational, and posttranslational programs activated in response to ER stress. To determine which UPR signaling pathway, if any, regulates XIAP, we used chemical-genetic constructs to specifically and sensitively activate IRE1, PERK, or ATF6 individually ([Figure 2A](#F2){ref-type="fig"}). To selectively activate IRE1, we used an IRE1 construct bearing an isoleucine-to-glycine substitution at residue 642, which enabled selective regulation of IRE1's RNase function by the small molecule 1NM-PP1 ([@B26]; [@B21]). To selectively activate PERK, we used a PERK fusion construct that joined the kinase domain of PERK to FK506-binding domains that enabled artificial dimerization and activation of Fv2E-PERK in the presence of the small molecule AP20187 ([@B28], [@B29]; [@B27]). To selectively activate ATF6, we expressed the 373--amino acid bZIP transcriptional activator domain of ATF6 (ATF6(373)) under the control of a tetracycline-responsive element ([@B19]; [@B5]). We previously demonstrated robust and selective activation of IRE1, PERK, or ATF6 using these chemical-genetic constructs in diverse mammalian cell types ([@B26], [@B27]; [@B19]).

![The PERK arm of the UPR down-regulates XIAP protein but not *Xiap* mRNA. (A) Schematic of chemical-genetic constructs to selectively activate individual UPR pathways in stable mammalian cell lines. IRE1 pathway is selectively activated using an IRE1\[I642G\] with 1NM-PP1 binding site. PERK pathway is selectively activated using Fv2E-PERK with AP20187 dimerizing chemical. ATF6 pathway is selectively activated using a tetracycline-inducible ATF6(373) (TetON-ATF6(373)). (B) Stable HEK293 cell lines bearing IRE1\[I642G\], Fv2E-PERK, or TetON-ATF6a (373) were treated with 5 μM 1NM-PP1, 1 nM AP20187, or 1 μg/ml doxycycline (Dox) for the indicated hours. Cell lysates were probed for XIAP or cleaved PARP (cPARP). (C) Stable HeLa cell lines bearing Fv2E-PERK or tetracycline-repressible ATF6(373) (TetOFF-ATF6(373)) were treated with 1 nM AP20187 or Dox-free media for the indicated duration, and cell lysates were probed for XIAP or cleaved PARP. (D) Cells stably expressing Fv2E-PERK were treated with AP20187 for the indicated durations, and *Xiap* mRNA levels were measured by qPCR and are shown relative to levels in untreated cells. (E) Schematic of GADD34 and salubrinal\'s effects on PERK signaling. (F) HEK293 cells were transfected with GADD34. Then 5 μg/ml Tm or 500 nM Tg was added, and cell lysates were immunoblotted for phosphorylated eIF2α levels. Total eIF2α levels served as a protein loading control. (G) GADD34-transfected cells were treated with Tm or Tg as indicated. Cell lysates were probed for XIAP. (H) Cells were treated with salubrinal as indicated. Cell lysates were probed for XIAP and phospho-eIF2α (eIF2α-P). For B, C, G, and H, actin served as a protein loading control.](1411fig2){#F2}

Using these tools, we saw a pronounced down-regulation of XIAP in both HEK and HeLa cells after PERK activation that was similar in kinetics and magnitude to the down-regulation of XIAP seen with tunicamycin or thapsigargin treatment (compare [Figure 2, B and C](#F2){ref-type="fig"}, with [Figure 1](#F1){ref-type="fig"}). Furthermore, in both HEK293 and HeLa cells, we saw that down-regulation of XIAP by artificial PERK activation correlated with onset of cell death as evident by morphological changes and emergence of cleaved PARP, similar to what we observed with extended tunicamycin and thapsigargin treatment ([Figure 2, B and C](#F2){ref-type="fig"}, middle, and [Figure 1](#F1){ref-type="fig"}). By contrast, we saw no effect on XIAP levels or induction of cleaved PARP after selective activation of IRE1's RNase function ([Figure 2B](#F2){ref-type="fig"}). We saw mild down-regulation of XIAP after ATF6 activation in HEK293 cells expressing tetracycline-inducible ATF6(373) ([Figure 2B](#F2){ref-type="fig"}) but not in HeLa cells expressing tetracycline-repressible ATF6(373) ([Figure 2C](#F2){ref-type="fig"}). These divergent effects between the tetracycline (tet)-inducible and tet-repressible ATF6 systems arise from negative effects of extended doxycycline exposure itself (unpublished data), and ATF6 signaling itself might also have a causal role in reduction of XIAP protein level in HEK293 cells. Taken together, these findings indicate that the PERK signaling arm of the UPR is the key UPR pathway responsible for down-regulating XIAP. Of interest, we saw no drop in *Xiap* mRNA levels after selective PERK activation, indicating that down-regulation of XIAP did not arise from reduced transcription ([Figure 2D](#F2){ref-type="fig"}).

A key proximal step in PERK signal transduction is phosphorylation of eIF2α. To further test the role of PERK signal transduction in regulating XIAP levels, we reduced levels of phosphorylated eIF2α by GADD34 phosphatase expression ([@B34]) or increased phosphorylated eIF2α levels by salubrinal addition ([@B2]; [Figure 2E](#F2){ref-type="fig"}). When we expressed GADD34, we partially ameliorated the down-regulation of XIAP induced by tunicamycin or thapsigargin ([Figure 2G](#F2){ref-type="fig"}) concomitant with blocking the increase in the levels of phosphorylated eIF2α normally seen after PERK activation by ER stress ([Figure 2F](#F2){ref-type="fig"}). Conversely, when we increased levels of phosphorylated eIF2α with salubrinal, we saw the opposite effect, with a corresponding drop in XIAP levels ([Figure 2H](#F2){ref-type="fig"}). Taken together, these findings show that PERK signaling via phosphorylation of eIF2α is an important step in regulating XIAP levels.

eIF2α phosphorylation attenuates *Xiap* mRNA translation
--------------------------------------------------------

Next we dissected how downstream steps in PERK signal transduction regulated XIAP. To investigate how PERK\'s control of translation via eIF2α phosphorylation affected XIAP, we introduced the Fv2E-PERK system into MEF cells defective for eIF2α phosphorylation to selectively activate PERK signaling without input from other signaling processes (e.g., other eIF2α kinases or UPR pathways; [@B45]). In wild-type *eIF2α^S/S^* cells stably expressing Fv2E-PERK (S/S^Fv2E-PERK^), AP20187 addition resulted in rapid activation of the PERK pathway, as evidenced by phosphorylation shift of Fv2E-PERK and phosphorylation of eIF2α ([Figure 3A](#F3){ref-type="fig"}). By contrast, in mutant *eIF2α^A/A^* cells stably expressing Fv2E-PERK (A/A^Fv2E-PERK^), AP20187 addition triggered strong phosphorylation shift of Fv2E-PERK without production of phosphorylated eIF2α ([Figure 3A](#F3){ref-type="fig"}). When we examined XIAP levels in S/S^Fv2E-PERK^ or A/A^Fv2E-PERK^ cells, we found that AP20187 triggered pronounced XIAP down-regulation (\>90%) in wild-type eIF2α S/S cells, but XIAP down-regulation was completely abrogated in mutant eIF2α A/A cells ([Figure 3A](#F3){ref-type="fig"}). Phosphorylated eIF2α down-regulated XIAP through attenuation of XIAP protein synthesis, as we saw a substantial drop in newly synthesized XIAP protein in wild-type eIF2α S/S cells but no reduction in XIAP synthesis in mutant eIF2α A/A cells after induction of ER stress or AP20187 addition in ^35^S metabolic-labeling XIAP synthesis studies ([Figure 3, B--D](#F3){ref-type="fig"}). These findings indicated that eIF2α was required for the down-regulation of XIAP caused by PERK activation and that phosphorylation of eIF2α triggered XIAP translational attenuation, contributing to the drop in steady-state XIAP levels seen with chronic ER stress and chronic PERK activation.

![PERK signaling attenuates XIAP translation through eIF2α phosphorylation. (A) Wild-type eIF2α^S/S^ MEFs expressing Fv2E-PERK (S/S^Fv2E-PERK^) and mutant eIF2α^A/A^ MEFs expressing Fv2E-PERK (A/A^Fv2E-PERK^) were treated with 1 nM AP20187, and cell lysates were probed for Fv2E-PERK, phosphorylated eIF2α, or XIAP. Actin served as a loading control. XIAP levels after AP20187 treatment from three different experiments were quantified by densitometry and are shown relative to XIAP levels in untreated cells. (B) Flowchart for metabolic labeling experiments in C and D. (C) Cells expressing Fv2E-PERK were pretreated with AP20187 for the indicated hours and metabolically labeled with 100 μCi of \[^35^S\]Met/Cys for 1 h. XIAP was immunoprecipitated, and ^35^S-labeled XIAP was visualized by phosphorimaging. Middle, total ^35^S-labeled protein levels after AP20187 treatment. (D) eIF2α^S/S^ and eIF2α^A/A^ MEFs were pretreated with 500 nM Tg for 1 h and labeled with 100 μCi of \[^35^S\]Met/Cys. XIAP was immunoprecipitated, and ^35^S-labeled XIAP was visualized by phosphorimaging. Middle, total ^35^S-labeled protein levels after Tg treatment. (C, D) Bottom, Coomassie-stained gel as loading control.](1411fig3){#F3}

ATF4 promotes XIAP protein degradation
--------------------------------------

PERK signaling also induces a transcriptional program via induction of ATF4 and CHOP transcription factors. To test the effects of ATF4 and CHOP on XIAP, we transduced cells with adenovirus carrying these transcription factors ([Figure 4A](#F4){ref-type="fig"}). Surprisingly, we found pronounced down-regulation of XIAP after ATF4 expression but not that of CHOP ([Figure 4A](#F4){ref-type="fig"}). eIF2α was not phosphorylated in these studies, indicating that ATF4's effects on XIAP did not occur via translational attenuation. To further test the role of ATF4 in regulating XIAP levels in response to PERK signaling, we introduced Fv2E-PERK into ATF4^^−^*/*^−^^ MEF cells. In wild-type ATF4^+/+^ cells stably expressing Fv2E-PERK (ATF4^+/+Fv2E-PERK^), AP20187 addition resulted in phosphorylation shift of Fv2E-PERK and strong phosphorylation of eIF2α ([Figure 4B](#F4){ref-type="fig"} and Supplemental Figure S1). By contrast, ATF4^^−^*/*^−^^ MEF cells expressing Fv2E-PERK (ATF4^^−^*/*^−^Fv2E-PERK^) also showed strong Fv2E-PERK and eIF2α phosphorylation after AP20187 addition but failed to induce downstream transcriptional targets ([Figure 4B](#F4){ref-type="fig"} and Supplemental Figure S1). When we examined XIAP levels in wild-type ATF4^+/+^ cells, we found that selective PERK activation triggered pronounced (\>90%) down-regulation in XIAP levels ([Figure 4B](#F4){ref-type="fig"}). However, we saw only partial down-regulation (∼50%) in mutant ATF4^^−^*/*^−^^ cells ([Figure 4B](#F4){ref-type="fig"}) after selective PERK activation despite identical Fv2E-PERK activation and phosphorylated eIF2α production in both ATF4^+/+^ and ATF4^^−^*/*^−^^ MEF cells ([Figure 4B](#F4){ref-type="fig"}). To further confirm the significance of ATF4 in XIAP down-regulation, we used short hairpin RNA (shRNA) to knock down *Atf4* in HEK293 cells stably expressing Fv2E-PERK and then examined effects on XIAP after ATF4 knockdown and PERK activation. In HEK293 cells expressing control shRNAs, we saw pronounced reduction of XIAP after addition of AP20187 and activation of the PERK pathway ([Figure 4C](#F4){ref-type="fig"}). By contrast and similar to our findings in the ATF4^^−^*/*^−^^ MEF cells, we found that *Atf4* knockdown in HEK cells significantly attenuated XIAP down-regulation after AP20187 addition and PERK pathway activation ([Figure 4C](#F4){ref-type="fig"}). These findings indicated that ATF4 was important for down-regulating XIAP in response to PERK activation by ER stress.

![ATF4 but not CHOP promotes XIAP degradation. (A) ATF4 or CHOP were adenovirally transduced into HeLa cells for 24 h, and XIAP, ATF4, or CHOP expression was detected by immunoblotting. (B) Wild-type ATF4 MEFs expressing Fv2E-PERK (ATF4(+/+)^Fv2E-PERK^) and ATF4-knockout MEFs expressing Fv2E-PERK (ATF4(^^−^*/*^−^^ )^Fv2E-PERK^) were treated with 1 nM AP20187, and cell lysates were probed for Fv2E-PERK, phosphorylated eIF2α, or XIAP. Changes in XIAP levels were quantified by densitometry from three experimental replicates and are shown relative to XIAP levels in untreated cells. Asterisk indicates statistical significance. (C) HEK293 cells stably expressing Fv2E-PERK were transfected with scrambled nonsilencing control (shCont) or *Atf4*-specific (shATF4) shRNAs. Cells were treated with 1 nM AP20187, and cell lysates were probed for phosphorylated eIF2α, ATF4, and XIAP. XIAP levels were quantified as before and are shown related to XIAP levels in untreated cells. Asterisk indicates statistical significance. (D) XIAP was immunoprecipitated from cells transduced with ATF4, and ubiquitin (top) or XIAP (bottom) were detected by immunoblotting. (E) HeLa cells were adenovirally transduced ATF4 for 18 h, treated with 50 μg/ml cycloheximide, and harvested at indicated time periods. Cell lysates were probed for XIAP (left), and XIAP levels were quantified and plotted from three experimental replicates (right). (F, G) Cells expressing Fv2E-PERK were treated with 1 nM AP20187, 10 μM MG132 (F), or 1 μM lactacystin (G) as indicated. Cell lysates were probed for XIAP. (H) Cells expressing Fv2E-PERK were treated with 1 nM AP20187 in the presence or absence of 25 μM pancaspase inhibitor zVAD as indicated. Cell lysates were probed for XIAP or cleaved PARP. Actin served as a loading control as indicated.](1411fig4){#F4}

Next we examined how ATF4 down-regulates XIAP. Microarray and RNA sequencing studies predict that ATF4's transcriptional targets include a number of ubiquitin ligases ([@B18]; [@B24]; [@B14]). Therefore we examined whether ATF4 down-regulated XIAP by promoting its degradation through the ubiquitin-proteasome degradation system. We found pronounced ubiquitination of XIAP after ATF4 overexpression ([Figure 4D](#F4){ref-type="fig"}), suggesting that ATF4 was promoting the destabilization and degradation of XIAP during PERK pathway activation. Indeed, when we examined XIAP protein stability after cycloheximide inhibition of protein synthesis, we found significantly faster decline in XIAP protein levels after overexpression of ATF4 ([Figure 4E](#F4){ref-type="fig"}). To further test whether proteasomal XIAP protein degradation was involved in PERK-induced XIAP down-regulation, we blocked proteasome function using MG132 or lactacystin. We found that proteasomal inhibition prevented the down-regulation of XIAP induced by PERK activation ([Figure 4, F and G](#F4){ref-type="fig"}). Caspases have also been reported to degrade XIAP ([@B8]). To test whether caspases played a role in XIAP down-regulation, we blocked caspase proteolysis using the pancaspase inhibitor zVAD. When we artificially activated PERK, we significantly inhibited production of caspase-cleaved PARP protein, but, in contrast, XIAP levels still dropped and were unaffected by zVAD addition ([Figure 4H](#F4){ref-type="fig"}). Taken together, these studies show that ATF4 promotes XIAP degradation and that the PERK signaling pathway down-regulates XIAP by two modes: 1) attenuation of de novo XIAP synthesis via eIF2α phosphorylation and 2) degradation of existing XIAP via ATF4 induction.

XIAP levels determine cell survival during ER stress
----------------------------------------------------

In our studies, down-regulation of XIAP correlated with the emergence of cell death arising from chronic ER stress. To establish causality between XIAP levels and ER stress-induced cell death, we compared the sensitivities of human colon carcinoma cell line HCT116 Xiap^+/+^ and HCT116 Xiap^^−^*/*^−^^ cells ([@B23]; [Figure 5A](#F5){ref-type="fig"}) to apoptosis triggered by extended tunicamycin and thapsigargin treatment. We saw increased PARP cleavage by immunoblotting and increased cell death by flow cytometry in HCT116 Xiap^^−^*/*^−^^ cells compared with HCT116 Xiap^+/+^ cells in response to tunicamycin and thapsigargin ([Figure 5, B and C](#F5){ref-type="fig"}). To further test the significance of XIAP in influencing ER stress-induced cell death, we reintroduced human XIAP back into HCT116 Xiap^^−^*/*^−^^ cells by stable overexpression ([Figure 5D](#F5){ref-type="fig"}) and compared sensitivities to tunicamycin and thapsigargin. In HCT116 Xiap^^−^*/*^−^^ cells reconstituted with XIAP, we saw significantly decreased PARP cleavage and decreased 7-aminoactinomycin D (7-AAD) labeling compared with the parental HCT116 Xiap^^−^*/*^−^^-knockout cells in response to ER stress--inducing agents ([Figure 5, E and F](#F5){ref-type="fig"}). These studies show that ambient intracellular XIAP levels prevent ER stress--induced cell death and that XIAP down-regulation triggered by extended ER stress sensitizes cells to apoptosis.

![XIAP enhances resistance to ER stress--induced cell death independent of CHOP. (A) HCT116 XIAP^+/+^ (XIAP WT) or XIAP^^−^/−^ (XIAP KO) cell lysates were probed for XIAP. (B) XIAP WT or XIAP KO cells were treated with 5 μg/ml Tm or 100 nM Tg. Cell lysates were probed for cleaved PARP. (C) XIAP WT or XIAP KO cells were treated with Tm or Tg. The number of 7-AAD positive cells was quantified by FACS and is shown relative to untreated cells. (D) Cell lysates from XIAP WT, XIAP KO, and XIAP KO cells stably reconstituted with human XIAP (XIAP Re) were probed for XIAP. (E) XIAP KO and XIAP Re cells were treated with Tm or Tg. Cell lysates were probed for cleaved PARP. (F) XIAP KO or XIAP Re cells were treated with Tm or Tg. The number of 7-AAD positive cells was quantified by FACS and is shown relative to untreated cells. (G) CHOP wild-type (WT) or knockout (KO) MEFs were treated with tunicamycin for 24 h at the indicated concentrations, and ATF4, CHOP, and cleaved PARP were detected by immunoblotting. (H) CHOP-KO MEFs and CHOP-KO MEFs expressing human XIAP were treated with tunicamycin as indicated. XIAP and PARP were detected by immunoblotting. Human myc-XIAP (top) has higher mobility than native murine XIAP (bottom). (A--H) Actin served as a protein loading control as indicated.](1411fig5){#F5}

CHOP is induced by PERK in response to ER stress, and CHOP-knockout (KO) cells are partially resistant to ER stress--induced cell death ([@B55]; [Figure 5G](#F5){ref-type="fig"}). We found no changes in XIAP levels after CHOP overexpression ([Figure 4A](#F4){ref-type="fig"}) or in CHOP-KO cells. Of interest, when we overexpressed XIAP in CHOP-KO cells, we were able to further increase their resistance to ER stress--induced apoptosis ([Figure 5H](#F5){ref-type="fig"}). These findings demonstrate that XIAP\'s antiapoptotic effects can operate independently of those caused by absence of CHOP.

Chronic PERK activation down-regulates multiple IAP-family proteins
-------------------------------------------------------------------

XIAP is a member of the IAP protein family, several of which have also been experimentally demonstrated to regulate cell survival in response to diverse stresses ([@B44]). We examined how extended PERK signaling affected other IAP family members. Similar to the down-regulation we saw with XIAP, we observed down-regulation for cIAP1, cIAP2, livin, survivin, and neuronal apoptosis inhibitory protein (NAIP) after extended PERK signaling ([Figure 6](#F6){ref-type="fig"}). These findings indicated that in addition to down-regulating XIAP, chronic PERK signaling also down-regulated related IAP-family proteins. This broad down-regulation of the IAP protein family likely further increases susceptibility to cell death seen with chronic ER stress.

![PERK signaling down-regulates multiple IAP-family proteins. HeLa cells stably expressing Fv2E-PERK were exposed to AP20187 for the indicated durations. Cell lysates were probed for XIAP, cIAP1, cIAP2, livin, survivin, and NAIP. Actin levels are shown as a loading control.](1411fig6){#F6}

DISCUSSION
==========

Metazoan cells respond to ER stress by activating intracellular UPR signaling pathways. IRE1, PERK, and ATF6 signaling initially provides an opportunity for cells to cope with and adapt to ER stress by enhancing the protein-folding capabilities of the ER and reducing the protein-folding load on the ER. However, if these measures fail to improve ER protein-folding fidelity, reduce ER stress, or restore ER homeostasis, the UPR "switches" from the initial adaptive phase to a maladaptive program that culminates in cell death. The precise molecules and mechanisms that link IRE1, PERK, or ATF6 at the ER membrane to activation of apoptotic pathways in the cytosol or other cellular compartments in response to irreparable ER stress are poorly understood. Here we identify a new molecular mechanism operating during the maladaptive phase of the UPR that links chronic ER stress to activation of the cytosolic cell death machinery. Specifically, we find that chronic ER stress removes an important brake against caspase activity through down-regulation of XIAP. Our findings demonstrate that the PERK arm of the UPR is the central mechanism driving XIAP down-regulation through translational attenuation mediated by phosphorylated eIF2α and degradation promoted by ATF4. Of interest, PERK activation leads to the production of proapoptotic CHOP transcriptional activator using the same signal transduction machinery: up-regulation of *Chop* translation by eIF2α phosphorylation and direct *Chop* transcriptional induction by ATF4 ([@B55]; [@B15]; [@B43]). We propose that the PERK pathway\'s up-regulation of CHOP coupled with its concomitant down-regulation of XIAP/IAPs creates a proapoptotic "double hit" that sensitizes cells to ER stress--induced cell death ([Figure 7](#F7){ref-type="fig"}).

![PERK promotes cell death through concomitant up-regulation of proapoptotic CHOP and down-regulation of antiapoptotic IAPs. Chronic ER stress activates PERK, leading to phosphorylation of eIF2α. Phosphorylation of eIF2α leads to production of ATF4 and attenuation of Xiap translation. ATF4 transcriptionally up-regulates proapoptotic CHOP and promotes XIAP degradation. The induction of CHOP coupled with loss of XIAP (double-hit model) sensitizes cells to apoptosis in response to chronic ER stress.](1411fig7){#F7}

The mechanism of CHOP-induced cell death is under extensive study. In our studies, we found no effect of CHOP expression on XIAP levels, indicating that CHOP does not regulate cell death through direct modulation of XIAP. Prior studies identified CHOP as transcriptionally up-regulating proapoptotic BH3 proteins Bim and Puma ([@B40]; [@B38]). However, these findings were seen in other experimental cell systems ([@B3]) and suggest that the mechanism of CHOP-induced cell death may vary across cell types. By contrast, we observed XIAP reduction in response to ER stress in all mammalian cell lines that we studied, and XIAP reduction inversely correlated with the emergence of apoptosis in all of these cell types. Therefore this molecular event---the down-regulation of XIAP---appears to be well-conserved step in the induction of ER stress--induced cell death.

IAPs were first identified in baculovirus, where they prevent infected cells from dying when they are generating immense numbers of newly enveloped virions. XIAP is the best-studied IAP in mammals and prevents apoptosis by directly binding and blocking the proteolytic activities of caspases and also promoting ubiquitination and degradation of target proteins, including caspases themselves. Given XIAP\'s important role in governing cell life/death fates, cells have evolved multiple mechanisms to regulate XIAP. The stress-activated NF-κB transcription factor has been shown to induce *Xiap* transcription ([@B47]). Human *Xiap* has a splicing variant that contains an internal ribosome entry site (IRES) in its 5′ untranslated region, and translation from the IRES-containing *Xiap* mRNA can be positively and negatively regulated by a dynamic ribonucleoprotein (RNP) complex containing heterogeneous nuclear RNP (hnRNP) C1/C2, HuR, La autoantigen, mdm2, hnRNP A1, and polypyrimidine tract-binding protein ([@B20]; [@B41]). XIAP protein is directly bound and inhibited by proteins, including SMAC/DIABLO, Omi/Htra2, and XAF ([@B44]). XIAP function and stability are further regulated by posttranslational modifications such as ubiquitination and S-nitrosylation ([@B33]; [@B51]). XIAP protein is a proteolytic target of activated caspases ([@B8]). Our studies reveal that the maladaptive phase of the UPR taps into the PERK pathway to down-regulate XIAP by inhibiting de novo XIAP synthesis, as well as by promoting destabilization and proteasomal degradation of extant XIAP protein. Given the many diverse modes of regulating XIAP function, additional mechanisms that negatively down-regulate XIAP during the maladaptive phase of the UPR are also likely to exist.

Of interest, positive up-regulation of IAPs may also contribute to the adaptive phase of the UPR. Induction and activation of cIAP1, cIAP2, and XIAP were observed in response to acute ER stress and PERK signaling in some cell types ([@B54]; [@B13]; [@B1]; [@B32]). These increased cellular levels of IAPs likely contribute to the adaptive phase of the UPR by inhibiting or enhancing degradation of caspase-3 and potentially other ER stress--activated caspases. cIAP1 was reported to promote the ubiquitination and ensuing degradation of the proapoptotic CHOP transcription factor that is induced by PERK signaling ([@B39]). Elimination of CHOP by IAP-mediated ubiquitination could further create a cellular environment conducive for the adaptive phase of the UPR and survival of ER stress. Coupled with our findings that chronic ER stress leads to down-regulation of XIAP, dynamic modulation of IAPs is an important determinant by which UPR switches between adaptive and maladaptive programs.

ER stress contributes to the pathogenesis and progression of many human diseases. Our findings identify several sequential intracellular signaling steps between dysfunction in the ER and down-regulation of an important inhibitor of apoptosis in the cytosol, beginning with chronic PERK signaling to translational attenuation and posttranslational destabilization of XIAP, all occurring concomitantly with PERK signaling\'s translational and transcriptional induction of CHOP. Targeting chronic PERK activation to prevent loss of XIAP and induction of CHOP could be beneficial in preventing the cell death and tissue injury observed in many ER stress--associated degenerative diseases. Indeed, dramatic enhancement of neuronal survival and function was seen after pharmacological inhibition of PERK in mice with prion disease associated with ER stress ([@B31]). Alternatively, accentuating the loss of XIAP could help target malignant cancers by reducing their resistance to ER stress--induced cell death.

MATERIALS AND METHODS
=====================

Cell culture and chemicals
--------------------------

HEK293, HeLa, HCT116, Huh7, and MEF cells were maintained in DMEM (Corning Cellgro, Manassas, VA) supplemented with 10% fetal bovine serum (FBS; Corning Cellgro), 100 U of penicillin (Sigma-Aldrich, St. Louis, MO), and 100 μg/ml streptomycin (Sigma-Aldrich) at 37°C and 5% CO~2~. ATF4^^−^*/*^−^^ MEF cells were further supplemented with 55 μM 2-mercaptoethanol (Invitrogen, Carlsbad, CA), and nonessential amino acids (Invitrogen) as previously described ([@B14]). The generation of HEK293 cells stably expressing IRE1\[I642G\], Fv2E-PERK, or tetracycline-inducible ATF6(373) was previously described ([@B26], [@B27]; [@B19]). The generation and characterization of MEFs carrying mutated eIF2α (S51A/S51A: eIF2α^A/A^), deletion of ATF4 (ATF4-KO), or deletion of CHOP (CHOP-KO) were previously described ([@B45]; [@B14]). HCT116 cells deleted for XIAP (HCT116-XIAP(^^−^*/*^−^^)) cells were generated as previously described ([@B7]).

To generate HeLa cells bearing Fv2E-PERK, HeLa-tet-off-FRT cells were cotransfected with pEF5/FRT/Fv2E-PERK and pOG44 plasmids, and stable HeLa/Fv2E-PERK clones were established. To generate HeLa cells bearing ATF6(373), HeLa-tet-off-FRT cells were transfected with pTRE-3xFLAG-ATF6(373), and stable clones were established. To generate eIF2α^A/A^, eIF2α^S/S^, ATF4-WT, and ATF4-KO MEF cells bearing Fv2E-PERK, MEFs were transduced with pBabe-puro-Fv2E-PERK, and stable clones were selected with 2.5 μg/ml puromycin (Corning Cellgro). To reconstitute XIAP in HCT116-XIAP(^^−^*/*^−^^) cells, pBabe-puro-XIAP was transduced, and stable clones were selected with puromycin. pLVX-puro-myc-XIAP was transduced into CHOP-KO MEF cells and selected with puromycin for establishment of CHOP-KO XIAP cells.

IRE1\[I642G\] was specifically activated by the ATP analogue 1NM-PP1 (Calbiochem, San Diego, CA) as previously described ([@B26]). Fv2E-PERK was specifically activated by AP20187 (ARIAD Pharmaceuticals, Cambridge, MA). Doxycycline (Sigma-Aldrich) was used to regulate ATF6(373) expression as previously described ([@B5]). Salubrinal was used as previously described ([@B2]). Adenovirus-mediated ATF4 or CHOP transduction into HeLa cells was carried out as described previously ([@B14]).

Western blotting and immunoprecipitation
----------------------------------------

For Western blotting analysis, total protein lysate was prepared with SDS lysis buffer (62.5 mM Tris-HCl, pH 6.8, 2% \[wt/vol\] SDS, 10% glycerol), and protein concentration was measured by Pierce BCA protein assay kit (Thermo Scientific, Rockford, IL). From 10 to 20 μg of protein was mixed with LDS sample buffer (Invitrogen) containing 100 mM dithiothreitol and incubated at 70°C for 5 min before loading onto 4--15% gradient SDS--PAGE gel (Bio-Rad, Hercules, CA). After SDS--PAGE, protein was electrically transferred to polyvinylidene fluoride membrane (Bio-Rad) in 1× Tris/glycine containing 20% methanol buffer for 1 h, and membrane was subsequently incubated for 1 h at room temperature in 5% nonfat dry milk in pH 7.6 Tris-buffered saline (TBS) containing 0.1% Tween-20 (TBS-T). Primary antibody was diluted in 5% bovine serum albumin (Cell Signaling Technology, Danvers, MA) in TBS-T, and membrane was incubated overnight at 4°C with gentle rotation. After incubation, the membrane was washed three times with 0.1% TBS-T for 5 min. After incubation with 1:3000 diluted horseradish peroxidase (HRP)--conjugated anti-mouse or anti-rabbit secondary antibody (Cell Signaling Technology) for 1 h at room temperature, membrane was washed three times with 0.1% TBS-T at room temperature, and HRP-catalyzed chemiluminescence was visualized with UVP BioSpectrum Imaging System (UVP, Upland, CA). Primary antibodies and dilutions used for were as follows: mouse anti-XIAP antibody, 1:1000 (BD Transduction Laboratories, San Diego, CA); rabbit anti--phospho eIF2α (Ser-51), 1:1000 (Cell Signaling); rabbit anti--cleaved PARP, 1:1000 (Cell Signaling); rabbit anti--cIAP-1, 1:1000 (Cell Signaling); rabbit anti--cIAP-2, 1:1000 (Cell Signaling); rabbit anti-livin, 1:1000 (Cell Signaling); rabbit anti-survivin, 1:1000 (Cell Signaling); rabbit anti-PARP, 1:1000 (Cell Signaling); mouse anti--FLAG M2, 1:5000 (Sigma-Aldrich); rabbit anti-HSP90, 1:1000 (GeneTex, San Antonio, TX); mouse anti-actin, 1:20,000 (Millipore, Bedford, MA); rabbit anti--FKBP-12 (Thermo Scientific); rabbit anti-NAIP, 1:1000 (Abcam, Cambridge, MA); mouse anti-CHOP, 1:1000 (Santa Cruz Biotechnology, Santa Cruz, CA); rabbit anti-CREB2, 1:1000 (Santa Cruz Biotechnology); and mouse anti-ubiquitin, 1:1000 (Santa Cruz Biotechnology).

For XIAP immunoprecipitation, cell lysates were prepared in NP-40 lysis buffer (20 mM Tris-HCl, 150 mM NaCl, 0.2% NP-40, 10% glycerol) supplemented with protease inhibitor cocktail (Sigma-Aldrich) and incubated on ice for 15 min. Lysate was centrifuged at 16,000 × *g* for 20 min at 4°C, and supernatant was immunoprecipitated with anti-XIAP (0.5 μg/sample; BD Transduction Laboratory) conjugated to 30 μl of Protein G Dynabeads (Invitrogen) with overnight incubation with gentle rotation at 4°C. Beads were washed five times with ice-cold phosphate-buffered saline (PBS) containing 0.02% Tween-20, and protein was eluted by boiling for 5 min in 30 μl of 2× LDS sample buffer.

Metabolic labeling and cycloheximide assay
------------------------------------------

For radiolabeling studies, cells were transferred to prewarmed methionine/cysteine (Met/Cys)-free DMEM (Corning Cellgro) with 10% dialyzed fetal bovine serum (Invitrogen), 100 U of penicillin (Sigma-Aldrich), 100 μg/ml streptomycin (Sigma-Aldrich), and 2 mM GlutaMAX (Invitrogen), and 100 μCi of \[^35^S\]Met/Cys was added for 1 h. Cells were harvested, and protein lysates and immunoprecipitation were performed as described. Lysates were resolved by SDS--PAGE, stained with SimplyBlue Safe Staining (Invitrogen), and dried on gel dryer (Bio-Rad) at 70°C for 20 min. Radioisotope incorporation was visualized by phosphorimaging (Typhoon Phosphor-Imager; GE Healthcare, Piscataway, NJ).

For evaluation of XIAP protein stability, a cycloheximide assay was carried out. HeLa cells were pretreated with or without Ad-Atf4 for 18 h and treated with 50 μg/ml cycloheximide to in inhibit protein synthesis. Cells were periodically harvested, and protein lysates were subjected to Western blotting for XIAP.

Molecular biology
-----------------

For quantitative PCR analysis of mRNA levels, total RNA was extracted with RNeasy Mini Kit (Qiagen, Germantown, MD) according to the manufacture\'s instruction. A 1-μg amount of RNA was reverse transcribed with iScript cDNA synthesis kit (Bio-Rad), and cDNA samples were subjected to PCR amplification with following gene-specific primer sets: human *Xiap*, 5′-AGAACACAGGCGACACTTTC-3′ and 5′-CCGTGCTTCATAATCTGCCA-3′; human *Rpl19*, 5′-ATGTATCACAGCCTGTACCTG-3′ and 5′-TTCTTGGTCTCTTCCTCCTTG-3′; mouse *Chop*, 5′-ACGGAAACAGAGTGGTCAGT­GC-3′ and 5′- CAGGAGGTGATGCCCACTGTTC-3′; and mouse *Rpl19*, 5′- ATGCCAACTCCCGTCAGCAG-3′ and 5′-TCATCCTTCTCATCCA­GGTCACC-3′.

Quantitative PCR was performed with iQ SYBR Green Supermix (Bio-Rad) on CFX96 real-time PCR (Bio-Rad). Analysis of the relative level of mRNA was normalized with the value of *Rpl19*, whose expression level is not affected by ER stress.

The shRNA fragments for nonsilencing (shCont) and human ATF4 (shATF4) were cloned into LMP vector at *Xho*I and *Eco*RI sites, and LMP-shCont and LMP-shATF4 were stably transfected into HEK/Fv2E-PERK cells.

Fluorescence-activated cell sorting cell death quantification
-------------------------------------------------------------

Cells were treated with tunicamycin or thapsigargin, gently trypsinized, collected into fluorescence-activated cell sorting (FACS) tubes, and centrifuged at 500 × *g* for 5 min at room temperature. Cell pellets were washed with FACS buffer (PBS, pH 7.4, 1% FBS, 0.1% sodium azide) and resuspended in FACS buffer supplemented with 1 μg/ml 7-AAD. The amount of dead cells incorporating 7-AAD was quantified by BD FACS Canto II (BD Biosciences).

Animals and retinal histologic and biochemical analyses
-------------------------------------------------------

All animals were maintained in accordance with Institutional Animal Care and Use Committee guidelines. P23H rhodopsin transgenic rat lines were created previously ([www.ucsfeye.net/mlavailRDratmodels.shtml](http://www.ucsfeye.net/mlavailRDratmodels.shtml)). P23H (line 2) transgenic rats mated with wild-type Sprague--Dawley animals, and retinas were collected from postnatal-day-90 animals and age-matched Sprague--Dawley littermate controls. For histological analysis, animals were killed and perfusion fixed. Eyes were bisected, postfixed, and embedded in an epoxy resin. One-micrometer-thick sections were cut through the optic nerve head and stained with toluidine blue. For biochemical analysis, retinas were removed from enucleated eyes and lysed in SDS lysis buffer.

Statistical analyses
--------------------

All results are presented as mean ± SD from at least three to eight individual samples per experimental condition. Student\'s *t* tests were performed to determine *p* values for paired groups. A value of *p* \< 0.05 was considered significant. \**p* \< 0.05, \*\**p* \< 0.01, and \*\*\**p* \< 0.001.
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ATF4

:   activating transcription factor 4

CHOP

:   C/EBP homologous protein

eIF2α

:   alpha subunit of eukaryotic translation initiation factor 2

ER

:   endoplasmic reticulum

PERK

:   PKR-like endoplasmic reticulum kinase

UPR

:   unfolded protein response

XIAP

:   X-linked inhibitor of apoptosis protein
